glp-1 pill 3 Companies at the Forefront of the Wars Clinically backed oral GLP Novo Nordisk launches Wegovy weight-loss

Patients should work with their prescriber to titrate the medication dose appropriately and avoid excessively restrictive eating patterns

Mild sensory aversions are common

No significant associations were observed for anorexia nervosa, broad depression, major depressive disorder, or suicide and intentional self-harm

The large share of this segment can be attributed to the growing adoption of Ozempic (semaglutide), The diabetes segment dominated the overall GLP-1 agonists market in 2024

Tursi, S

From first being prescribed for diabetes management to now being used for weight loss, GLP-1s have caused health care providers and insurers to examine the long-term effects of the drug and the costs associated with their use